Tenor Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Tenor Capital Management’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Hold	300,000	–	–	0.05%	275
2026 Q1	$3.17M	Hold	300,000	–	–	0.05%	252
2025 Q4	$3.17M	Hold	300,000	–	–	0.04%	234
2025 Q3	$3.15M	Hold	300,000	–	–	0.04%	204
2025 Q2	$3.13M	Hold	300,000	–	–	0.04%	198
2025 Q1	$3.07M	Hold	300,000	–	–	0.04%	158
2024 Q4	$2.99M	Buy	+300,000	New	+$2.99M	0.04%	147

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tenor Capital Management's OACC Position: Q2 2026 in Review

Tenor Capital Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 300,000 shares worth $3.21M. The position accounts for 0.05% of the portfolio, ranked #275.

Tenor Capital Management first reported a position in OACC in Q4 2024 and has held it in 7 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

Tenor Capital Management held 300,000 shares of Oaktree Acquisition Corp III Life Sciences worth $3.21M as of Q2 2026.
Tenor Capital Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences made up 0.05% of Tenor Capital Management's portfolio in Q2 2026, its #275 holding.
Tenor Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 7 quarters since.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Tenor Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.